whats glp-1 Medications – Community Education How GLP-1 medications are transforming

You can start your weight loss journey with confidence, knowing you have dependable support

The least you can do is check in on them regularly

Back to Journals Drug Design, Development and Therapy Volume 16 The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases Authors Cheng D, Yang S, Zhao X, Wang G Received 5 November 2021 Accepted for publication 18 February 2022 Published 14 March 2022 Volume 2022:16 Pages 665684 DOI Checked for plagiarism Yes Review by Single anonymous peer review Peer reviewer comments 2 Editor who approved publication: Dr Tuo Deng Dihe Cheng, Shuo Yang, Xue Zhao, Guixia Wang Department of Endocrinology and Metabolism, The First Hospital of Jilin University, Changchun, 130021, Peoples Republic of China Correspondence: Guixia Wang

However, natural GLP-1 can easily be degraded by dipeptidyl peptidase 4 (DPP-4) in vivo and lose its activity

Cell Chem

258266, Accessed 2 Feb